Ajinomoto (2802) Corporate presentation summary
Event summary combining transcript, slides, and related documents.
Corporate presentation summary
4 Sep, 2026Company overview
Operates 121 affiliated companies in 40 countries and regions, with over 34,700 employees and 126 factories as of March 2026.
Founded in 1909, with a mission to contribute to society through food and nutrition improvement.
Strategic vision and sustainability
Aspires to contribute to well-being globally using "AminoScience," aiming to help extend healthy life expectancy for 1 billion people and reduce environmental impact by 50%.
Focuses on sustainable agrifood systems and resilient business models.
Core business and innovation
Leverages amino acid research for diverse applications in food, healthcare, and fine chemicals.
Applies proprietary technologies to create value in seasonings, frozen foods, healthcare, and electronic materials.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Ajinomoto
- Record Q1 sales and profit led to upward full-year guidance amid strong electronic materials demand.2802
Q1 2027 - Marketing and digital transformation drive ambitious 2030 growth, brand, and ESG targets.2802
Investor update - Global leader in amino acid science targets growth, health impact, and major sustainability gains.2802
Investor presentation - AI-driven demand and innovation boost ABF growth, margins, and capacity expansion.2802
Investor update - Record sales and profit highs, with raised full-year profit outlook and strong segment momentum.2802
Q3 2026 - Doubling medical food sales by 2030 through 20%+ growth, innovation, and global expansion.2802
Investor update - CDMO revenue is set to triple by FY2030 as Forge Biologics drives gene therapy growth.2802
Investor Day 2024 - Sales up 7.7% with record profit, but net profit fell 12% on tax; guidance unchanged.2802
Q1 2025 - Record sales and profit growth led to upward forecasts and increased shareholder returns.2802
Q2 2025